Erin Rich is an Associate Professor in the Department of Neuroscience at Icahn School of Medicine at Mount Sinai and the Friedman Brain Institute. She joined the faculty in 2017. Her work focuses on the neural basis of cognitive and affective processing. The laboratory uses behavioral and neurophysiological approaches to study how rewards and punishments influence cognitive processes such as learning, memory and decision-making. Erin received a bachelor’s degree from Tufts University, an MD and PhD in Neuroscience from Mount Sinai School of Medicine under the Medical Scientist Training Program. Prior to joining the faculty, she was a post-doctoral fellow at the University of California, Berkeley.
Learn more about the Rich Lab.
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Neuroscience [NEU]-
2020
Circuit mechanisms of self-organized cognitive strategies -
2019
NARSAD Young Research Investigator Grant -
2019
FBI Research Scholars Award -
2018
Pew Scholars Program in Biomedical Sciences -
2018
Whitehall Foundation Research Grant -
2015
K08 Mentored Clinical Scientist Research Development Award -
2012
Hilda and Preston Davis Foundation Postdoctoral Fellowship in Eating Disorders Research -
2010
Basic Science Best Achievement Award for Paper Published in 2009 -
2006
Mount Sinai Graduate School Teaching Award -
2005
Kirschstein NRSA Predoctoral Fellowship -
2002
Audrey Butvay Gruss Science Award -
2002
Benjamin Brown Scholarship -
2001
Poskitt Scholarship for Biology Undergraduate -
1999
Howard Hughes Undergraduate Research Grant
Addiction, Behavior, Brain, Cerebral Cortex, Cognitive Neuroscience, Computational Neuroscience, Depression, Electrophysiology, Extracellular Unit Recording, Memory, Neural Code, Neural Networks, Neurobiology, Neuromodulation, Neurophysiology, Neuroscience, Prefrontal Cortex, Systems Neuroscience
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Rich did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.